Whole body diffusion weighted MRI--a new view of myeloma.

作者: Christina Messiou , Martin Kaiser

DOI: 10.1111/BJH.13509

关键词:

摘要: The recent consensus statement from the International Myeloma Working Group has introduced role of whole body (WB) magnetic resonance imaging (MRI) into management pathway for patients with multiple myeloma. speed, coverage and high sensitivity WB diffusion weighted (DW)-MRI unique capability to quantify both burden disease response treatment led increasing implementation at leading centres worldwide malignant marrow disease, primary metastatic. DW-MRI is likely have a significant impact on decisions pathways This review will introduce basic principles DW-MRI, present current evidence myeloma discuss practicalities exciting future applications.

参考文章(48)
Marc Van Cauteren, Taro Takahara, Tomohiro Yamashita, Seiei Yasuda, Yutaka Imai, Seiji Nasu, Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiation Medicine. ,vol. 22, pp. 275- 282 ,(2004)
Christina Messiou, Nandita M. deSouza, Metastasis imaging: Current concepts and future challenges Cancer Biomarkers. ,vol. 7, pp. 171- 172 ,(2011) , 10.3233/CBM-2010-0202
L A Moulopoulos, M A Dimopoulos, T L Smith, D M Weber, K B Delasalle, H I Libshitz, R Alexanian, Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma Journal of Clinical Oncology. ,vol. 13, pp. 251- 256 ,(1995) , 10.1200/JCO.1995.13.1.251
E Kastritis, E Terpos, L Moulopoulos, M Spyropoulou-Vlachou, N Kanellias, E Eleftherakis-Papaiakovou, M Gkotzamanidou, M Migkou, M Gavriatopoulou, M Roussou, A Tasidou, M A Dimopoulos, Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease. Leukemia. ,vol. 27, pp. 947- 953 ,(2013) , 10.1038/LEU.2012.309
Madhav V. Dhodapkar, Rachael Sexton, Sarah Waheed, Saad Usmani, Xenofon Papanikolaou, Bijay Nair, Nathan Petty, John D. Shaughnessy, Antje Hoering, John Crowley, Robert Z. Orlowski, Bart Barlogie, Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120) Blood. ,vol. 123, pp. 78- 85 ,(2014) , 10.1182/BLOOD-2013-07-515239
Elena Zamagni, Francesca Patriarca, Cristina Nanni, Beatrice Zannetti, Emanuela Englaro, Annalisa Pezzi, Paola Tacchetti, Silvia Buttignol, Giulia Perrone, Annamaria Brioli, Lucia Pantani, Carolina Terragna, Francesca Carobolante, Michele Baccarani, Renato Fanin, Stefano Fanti, Michele Cavo, Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation Blood. ,vol. 118, pp. 5989- 5995 ,(2011) , 10.1182/BLOOD-2011-06-361386
Lia A. Moulopoulos, Kengo Yoshimitsu, Dennis A. Johnston, Norman E. Leeds, Herman I. Libshitz, MR prediction of benign and malignant vertebral compression fractures Journal of Magnetic Resonance Imaging. ,vol. 6, pp. 667- 674 ,(1996) , 10.1002/JMRI.1880060416
S. Narquin, P. Ingrand, I. Azais, V. Delwail, R. Vialle, S. Boucecbi, J.-P. Tasu, Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma. Diagnostic and interventional imaging. ,vol. 94, pp. 629- 636 ,(2013) , 10.1016/J.DIII.2013.01.005
S.L. Giles, N.M. deSouza, D.J. Collins, V.A. Morgan, S. West, F.E. Davies, G.J. Morgan, C. Messiou, Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden Clinical Radiology. ,vol. 70, pp. 614- 621 ,(2015) , 10.1016/J.CRAD.2015.02.013
Bradford A. Moffat, Thomas L. Chenevert, Charles R. Meyer, Paul E. Mckeever, Daniel E. Hall, Benjamin A. Hoff, Timothy D. Johnson, Alnawaz Rehemtulla, Brian D. Ross, The Functional Diffusion Map: An Imaging Biomarker for the Early Prediction of Cancer Treatment Outcome Neoplasia. ,vol. 8, pp. 259- 267 ,(2006) , 10.1593/NEO.05844